Q32 Bio has launched with $46m from investors including University of Colorado to target autoimmune and inflammatory diseases.

Cell sorting technology business Thinkcyte has closed an OUVC-backed series A round intended to progress its joint research and unlock an expansion into the US.

Q32 Bio has launched with $46m from investors including Sanofi Ventures and Children’s Hospital Colorado to target autoimmune and inflammatory diseases.

Fuyo General Lease and Itochu Technology Ventures both invested as the cell-sorting technology developer completed a $15.3m round.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Allianz Life Ventures invested in the artificial intelligence software developer as part of a round that took its total funding to $14.5m.

Aucfan Incubate was among the investors in an $11.2m round that will fund construction of the insect feedstock provider's second production plant.

Axovant's seizure treatment spinoff has closed its series A round having received more than $133m in equity funding and $74.5m in project financing.

MIT's fusion energy spinout Commonwealth Fusion Systems secured the return of The Engine and Eni for a $84m series A2 round that followed a $115m series A last year.

Equinor and Eni Next contributed to an $84m round for nuclear fusion technology startup Commonwealth Fusion Systems following a $115m series A last year.